Bay Area biotechs soar on coattails of AstraZeneca cancer drug study
September 17, 2021 at 17:59 PM EDT
The companies have drugs in clinical trials that target an enzyme implicated in poor prognosis for patients.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
